Actively Recruiting

Phase Not Applicable
Age: 18Years +
MALE
ID06259279

High Impact Training to Patients with Prostate Cancer and Bone Metastases

Led by Copenhagen University Hospital at Herlev · Updated on 2025-02-13

102

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the effects, safety, and feasibility of brief, high-impact exercise focused on bones in men with prostate cancer that has spread to the bones. This study aims to assess changes in bone health, body composition, physical function, quality of life, falls, hospitalizations, and the impact of resistance training on immune responses in blood and tumor tissue. The study is randomized and involves patients treated with hormone therapy for metastatic prostate cancer. Participants in the intervention group will engage in a 32-week exercise program at the hospital, with supervised sessions twice a week lasting about 30 minutes each. The first eight weeks involve low-impact and bodyweight exercises to gradually learn movement patterns and use weight training equipment safely. Resistance exercises like deadlifts, overhead presses, and squats are then performed at high intensity for the remaining weeks. Blood samples and tumor biopsies will be collected during the study to analyze immune responses. During the study, participants will undergo multiple assessments including lower body strength tests at baseline, 16, 32, and 44 weeks. Changes in body fat, muscle mass, bone mineral density, handgrip strength, fatigue, quality of life, physical activity, and safety events will be monitored throughout the study and for about one year. Hospitalizations, falls, and patient experiences will also be recorded. Immune responses will be specifically studied at several time points. This comprehensive monitoring helps understand how the exercise affects patients over time.

CONDITIONS

Brief Title

High Impact Training to Patients with Prostate Cancer and Bone Metastases

Who Can Participate

Age: 18Years +
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with metastatic hormone sensitive prostate cancer (mHSPC)
  • Presence of bone metastases confirmed by recent imaging (Bone scan, CT, MRI, and/or PET)
  • Started androgen deprivation therapy less than 12 months ago; additional treatments like radiotherapy, novel hormone agents, or docetaxel allowed
  • Eastern Cooperative Oncology Group (ECOG) performance status score less than 2
  • Able to speak and read Danish and provide signed informed consent
  • Ambulatory without walking aids
Not Eligible

You will not qualify if you...

  • Any physical condition that interferes with performing physical exercise training
  • Musculoskeletal, cardiovascular, or neurological conditions preventing exercise
  • Bone pain requiring opioid treatment
  • Planned or prior palliative radiation therapy to the bone
  • Major surgery within the past 6 months

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 32 weeks

Participants assigned to the intervention group participate in a 32-week, twice-weekly, 30-minute supervised high impact training program at the hospital. The first 8 weeks focus on self-bodyweight and low-impact exercises to learn movement patterns and transition safely to high-intensity resistance exercises performed at 80% to 85% of 1 repetition maximum.

Twice-weekly supervised sessions

Follow-up

Duration - Approximately 12 weeks after treatment

Participants are monitored for safety, physical function, quality of life, and immune responses up to approximately 12 weeks after the intervention ends, including assessments up to 44 weeks and qualitative evaluations up to 6 months after study completion.

1 to 2 visits at weeks 44 and up to 6 months post-study

Trial Site Locations

Total: 1 location

1

Herlev and Gentofte Hospital

Herlev, Herlev, Denmark, 2730

Actively Recruiting

Loading map...

Research Team

A

Anne-Mette Ragle, PhD student

P

Peter Busch Østergren, MD, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Similar Trials

177Lu-PSMA as a Systemic Adjuvant Treatment in Patients With...

Prostate Cancer

Actively Recruiting

1 location

A Phase 1b Study of 177Lu-PSMA-617 Combined With Liver Direc...

Metastatic Prostate Cancer

Actively Recruiting

1 location

18F-PSMA-1007 PET/CT Imaging in Prostate Cancer Phase III Ac...

Prostate Cancer

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

High-intensity resistance and impact training for patients with hormone-sensitive prostate cancer and bone metastases-study protocol of a randomized clinical trial.

Anne-Mette Ragle, Marta Kramer Mikkelsen, Anders Vinther...

https://pubmed.ncbi.nlm.nih.gov/40722114